Review article · 2004 · Open access
Use and Abuse of HOMA Modeling
Diabetes Care, 27(6), 1487–1495 · Published 1 June 2004 · DOI 10.2337/diacare.27.6.1487
In brief
“Use and Abuse of HOMA Modeling” is a 2004 review article by Tara M Wallace and 2 co-authors, published in Diabetes Care. OpenAlex counts 5,224 citations as of 15 November 2026, which puts it in the top 1% of works published in 2004 by citations. It is open access: the full text is free to read at Diabetes Care.
- Citations
- 5,224
- Most cited in
- 2021 (348)
- Field-weighted impact
- 13.10
- References
- 44
- Authors
- 3
Abstract
Homeostatic model assessment (HOMA) is a method for assessing beta-cell function and insulin resistance (IR) from basal (fasting) glucose and insulin or C-peptide concentrations. It has been reported in >500 publications, 20 times more frequently for the estimation of IR than beta-cell function. This article summarizes the physiological basis of HOMA, a structural model of steady-state insulin and glucose domains, constructed from physiological dose responses of glucose uptake and insulin production. Hepatic and peripheral glucose efflux and uptake were modeled to be dependent on plasma glucose and insulin concentrations. Decreases in beta-cell function were modeled by changing the beta-cell response to plasma glucose concentrations. The original HOMA model was described in 1985 with a formula for approximate estimation. The computer model is available but has not been as widely used as the approximation formulae. HOMA has been validated against a variety of physiological methods. We review the use and reporting of HOMA in the literature and give guidance on its appropriate use (e.g., cohort and epidemiological studies) and inappropriate use (e.g., measuring beta-cell function in isolation). The HOMA model compares favorably with other models and has the advantage of requiring only a single plasma sample assayed for insulin and glucose. In conclusion, the HOMA model has become a widely used clinical and epidemiological tool and, when used appropriately, it can yield valuable data. However, as with all models, the primary input data need to be robust, and the data need to be interpreted carefully.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Wallace, T. M., Lévy, J., & Matthews, D. R. (2004). Use and Abuse of HOMA Modeling. Diabetes Care, 27(6), 1487–1495. https://doi.org/10.2337/diacare.27.6.1487
MLA 9
Wallace, Tara M, et al. “Use and Abuse of HOMA Modeling.” Diabetes Care, vol. 27, no. 6, 2004, pp. 1487–1495. https://doi.org/10.2337/diacare.27.6.1487.
Chicago
Wallace, Tara M, J Lévy, and David Richard Matthews. 2004. “Use and Abuse of HOMA Modeling.” Diabetes Care 27 (6): 1487–1495. https://doi.org/10.2337/diacare.27.6.1487.
Harvard
Wallace, T. M., Lévy, J. and Matthews, D. R. (2004) ‘Use and Abuse of HOMA Modeling’, Diabetes Care, 27(6), pp. 1487–1495. doi:10.2337/diacare.27.6.1487.
IEEE
T. M. Wallace, J. Lévy, and D. R. Matthews, “Use and Abuse of HOMA Modeling,” Diabetes Care, vol. 27, no. 6, pp. 1487–1495, 2004, doi: 10.2337/diacare.27.6.1487.
BibTeX
@article{wallace2004abuse,
title = {{Use and Abuse of HOMA Modeling}},
author = {Wallace, Tara M and Lévy, J and Matthews, David Richard},
journal = {Diabetes Care},
year = {2004},
volume = {27},
number = {6},
pages = {1487--1495},
doi = {10.2337/diacare.27.6.1487},
url = {https://doi.org/10.2337/diacare.27.6.1487}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 234 | |
| 2018 | 286 | |
| 2019 | 301 | |
| 2020 | 306 | |
| 2021 | 348 | |
| 2022 | 342 | |
| 2023 | 293 | |
| 2024 | 321 | |
| 2025 | 264 | |
| 2026 | 234 |
Its field-weighted citation impact is 13.10: it has been cited 13.10 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- HOMA
- HOMA-IR
- insulin resistance
- beta-cell function
- HOMA-β
- glucose uptake
- hepatic glucose production
- C-peptide
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Wallace, T. M., Lévy, J., & Matthews, D. R. (2004). Use and Abuse of HOMA Modeling. Diabetes Care, 27(6), 1487–1495. https://doi.org/10.2337/diacare.27.6.1487
How many times has this paper been cited?
5,224 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at Diabetes Care.
Who wrote this paper?
Tara M Wallace, J Lévy, David Richard Matthews.
What is the DOI of this paper?
10.2337/diacare.27.6.1487. The permanent link is https://doi.org/10.2337/diacare.27.6.1487.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.